Big Data in Genomics: How Neo4j helps to develop new drugs
But with big data comes a big question: How do we transform unstructured data into actionable knowledge? In the case of biomedical research, the key problem is to integrate the large pile of highly heterogenous data and use it for personalized therapies and drug development. Graph databases are an ideal way to represent biomedical knowledge and offer the necessary flexibility to keep up with scientific progress. A well-designed data model and Cypher queries can deliver in seconds what previously took days of manual analysis.
YOU MAY ALSO LIKE:
- Deep Learning Fundamentals with Leonardo De Marchi (Online Workshop on 12th - 15th September 2022)
- Improving Software Quality through Data with Markus Harrer (Online Workshop on 14th - 15th November 2022)
- E106 - CLASSIC - Steve Nouri - On Growth and Branding for AI Professionals (Online Meetup on 26th June 2022)
- Getting Geospatial Data on The Web (SkillsCast recorded in February 2022)
- Deep Learning with F#: An Experience Report (SkillsCast recorded in October 2021)
Thank you to our sponsors and partners
Platinum
Big Data in Genomics: How Neo4j helps to develop new drugs
Martin Preusse
Martin Preusse studied biochemistry at TU München and is currently finishing his PhD in bioinformatics at the Institute for Computational Biology (Helmholtz Zentrum München, Germany). He focuses on integration of heterogeneous experimental data sets to understand cellular decision-making. Next to academic research, he is working on a startup that develops data solutions for biomedical research and biotech industry.